INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 412m ago
HOUSE PTR12m ago
SEC 13F12m ago
ROBINHOOD CHAIN12m ago
HOUSE PTR/PurchaseVerified data

Gilbert Ray Cisneros, Jr. bought NEO

Self · NEOGENOMICS INC · NeoGenomics, Inc. - Common Stock

Side
BUY
Value range
$1,001 – $15K
Shares
Not disclosed
Price
—
Executed
Aug 7, 2026
Disclosed
Sep 10, 2026
Disclosure timeline34 days from execution to publication · legal deadline 45 days
Aug 7 executedSep 10, 2026 disclosed

NEO · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
28/ 100 · ROUTINE
Methodology →
  • Transaction type+14 / 20

    Purchase

  • Relative size+2 / 25

    Disclosed range starting at $1K

  • Filing timing+4 / 15

    Disclosed 34 days after execution (STOCK Act deadline: 45)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · NEO

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    17
    OC
    Olivo Alicia CEVP, GC & Business Development
    NEONEOGENOMICS INC
    Option exercise
    		M—
    59.4K sh
    		Jan 13, 2026Jan 15, 2026
    traded Jan 13, 2026
    		+2dSEC FORM 4

    Evidence

    13
    OC
    Olivo Alicia CEVP, GC & Business Development
    NEONEOGENOMICS INC
    Tax withholding
    		F—
    15.1K sh
    		Jan 13, 2026Jan 15, 2026
    traded Jan 13, 2026
    		+2dSEC FORM 4

    Evidence

    21
    SW
    Stone WarrenPres & Chief Operating Officer
    NEONEOGENOMICS INC
    Option exercise
    		M—
    59.4K sh
    		Jan 13, 2026Jan 15, 2026
    traded Jan 13, 2026
    		+2dSEC FORM 4

    Evidence

    13
    SW
    Stone WarrenPres & Chief Operating Officer
    NEONEOGENOMICS INC
    Tax withholding
    		F—
    15.1K sh
    		Jan 13, 2026Jan 15, 2026
    traded Jan 13, 2026
    		+2dSEC FORM 4

    Evidence

    16
    OC
    Olivo Alicia CEVP, GC & Business Development
    NEONEOGENOMICS INC
    Option exercise · 10b5-1 plan
    		M$90K
    8,977 sh
    		Nov 25, 2025Nov 28, 2025
    traded Nov 25, 2025
    		+3dSEC FORM 4

    Evidence

    25
    OC
    Olivo Alicia CEVP, GC & Business Development
    NEONEOGENOMICS INC
    Open-market sale · 10b5-1 plan
    		SELL$251K
    20.9K sh
    		Nov 25, 2025Nov 28, 2025
    traded Nov 25, 2025
    		+3dSEC FORM 4

    Evidence

    13
    OC
    Olivo Alicia CEVP, GC & Business Development
    NEONEOGENOMICS INC
    Option exercise · 10b5-1 plan
    		M—
    8,977 sh
    		Nov 25, 2025Nov 28, 2025
    traded Nov 25, 2025
    		+3dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    House Periodic Transaction Report
    Publisher
    Clerk of the U.S. House of Representatives
    Document ID
    20035390

    Timestamps

    Event (reported)
    Aug 7, 2026
    Published
    Sep 10, 2026
    Ingested by INSIDER
    Nov 4, 22:39 UTC
    Last re-read
    Nov 5, 15:29 UTC

    Extracted facts

    Filer
    Gilbert Ray Cisneros, Jr.
    Role
    Self
    Transaction
    PurchaseAs filed: “P”
    Asset
    NeoGenomics, Inc. - Common Stock
    Ticker
    NEO
    Reported value
    $1,001 – $15KAs filed: “$1,001 - $15,000”
    Execution date (reported)
    Aug 7, 2026
    Notification date (reported)
    Sep 4, 2026
    Days from execution to publication
    34

    Calculation

    Midpoint = (low + high) / 2. Used only to rank and sum ranges; the true value can be anywhere in the range.

    • Low: $1,001
    • High: $15,000

    = $8,001

    What this establishes

    Gilbert Ray Cisneros, Jr. reported a purchase of NeoGenomics, Inc. - Common Stock. Members report a value range, not an exact amount, and do not report share counts or prices. Dates are as entered by the filer. A trade report is not evidence of wrongdoing.

    Extraction

    Method
    PDF text extraction
    Confidence
    1.00
    Self
    Gilbert Ray Cisneros, Jr.bioguide:C001123
    Issuer
    NEOGENOMICS INCcik:0001077183

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.